Search research articles
Contact Us
Filters
Showing results (341-350 of 420) with videos related to
Page
of 42
Sort By:
Open Forum Infectious Diseases
|
May 14, 2025
Aztreonam-avibactam Demonstrates Potent Activity Against Carbapenem-resistant Enterobacterales Collected From US Medical Centers Over a 6-year Period (2017-2022)
Krisztina M Papp-Wallace, Helio S Sader, Joshua M Maher, et al.
International Journal of Antimicrobial Agents
|
December 29, 2004
Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program
Helio S Sader, Mariana Castanheira, Rodrigo E Mendes, et al.
Antimicrobial Agents and Chemotherapy
|
March 20, 2013
Potency and spectrum of activity of AN3365, a novel boron-containing protein synthesis inhibitor, tested against clinical isolates of Enterobacteriaceae and nonfermentative Gram-negative bacilli
Rodrigo E Mendes, M R K Alley, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy
|
October 25, 2017
Antimicrobial Activities of Aztreonam-Avibactam and Comparator Agents against Contemporary (2016) Clinical Enterobacteriaceae Isolates
Helio S Sader, Rodrigo E Mendes, Michael A Pfaller, et al.
Open Forum Infectious Diseases
|
March 22, 2019
Antimicrobial Susceptibility of <i>Streptococcus pneumoniae</i> from North America, Europe, Latin America, and the Asia-Pacific Region: Results From 20 Years of the SENTRY Antimicrobial Surveillance Program (1997-2016)
Helio S Sader, Rodrigo E Mendes, Jennifer Le, et al.
Diagnostic Microbiology and Infectious Disease
|
April 16, 2017
Cefiderocol MIC quality control ranges in iron-depleted cation-adjusted Mueller-Hinton broth using a CLSI M23-A4 multi-laboratory study design
Michael D Huband, Akinobu Ito, Masakatsu Tsuji, et al.
Open Forum Infectious Diseases
|
March 22, 2019
Variations in the Occurrence of Resistance Phenotypes and Carbapenemase Genes Among <i>Enterobacteriaceae</i> Isolates in 20 Years of the SENTRY Antimicrobial Surveillance Program
Mariana Castanheira, Lalitagauri M Deshpande, Rodrigo E Mendes, et al.
Antimicrobial Agents and Chemotherapy
|
March 25, 2024
<i>In vitro</i> development of resistance against antipseudomonal agents: comparison of novel β-lactam/β-lactamase inhibitor combinations and other β-lactam agents
Mariana Castanheira, John H Kimbrough, Jill Lindley, et al.
Journal of Clinical Microbiology
|
September 16, 2011
Determination of disk diffusion and MIC quality control ranges for GSK1322322, a novel peptide deformylase inhibitor
James E Ross, Nicole E Scangarella-Oman, Linda A Miller, et al.
Journal of Global Antimicrobial Resistance
|
December 7, 2020
Antimicrobial activity of dalbavancin against clinical isolates of coagulase-negative staphylococci from the USA and Europe stratified by species
Helio S Sader, Cecilia G Carvalhaes, Jennifer M Streit, et al.
Page
of 42
Search research articles
Search
Showing results (341-350 of 420) with videos related to
Sort By:
Page
of 42
Open Forum Infectious Diseases
|
May 14, 2025
Aztreonam-avibactam Demonstrates Potent Activity Against Carbapenem-resistant Enterobacterales Collected From US Medical Centers Over a 6-year Period (2017-2022)
Krisztina M Papp-Wallace, Helio S Sader, Joshua M Maher, et al.
International Journal of Antimicrobial Agents
|
December 29, 2004
Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program
Helio S Sader, Mariana Castanheira, Rodrigo E Mendes, et al.
Antimicrobial Agents and Chemotherapy
|
March 20, 2013
Potency and spectrum of activity of AN3365, a novel boron-containing protein synthesis inhibitor, tested against clinical isolates of Enterobacteriaceae and nonfermentative Gram-negative bacilli
Rodrigo E Mendes, M R K Alley, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy
|
October 25, 2017
Antimicrobial Activities of Aztreonam-Avibactam and Comparator Agents against Contemporary (2016) Clinical Enterobacteriaceae Isolates
Helio S Sader, Rodrigo E Mendes, Michael A Pfaller, et al.
Open Forum Infectious Diseases
|
March 22, 2019
Antimicrobial Susceptibility of <i>Streptococcus pneumoniae</i> from North America, Europe, Latin America, and the Asia-Pacific Region: Results From 20 Years of the SENTRY Antimicrobial Surveillance Program (1997-2016)
Helio S Sader, Rodrigo E Mendes, Jennifer Le, et al.
Diagnostic Microbiology and Infectious Disease
|
April 16, 2017
Cefiderocol MIC quality control ranges in iron-depleted cation-adjusted Mueller-Hinton broth using a CLSI M23-A4 multi-laboratory study design
Michael D Huband, Akinobu Ito, Masakatsu Tsuji, et al.
Open Forum Infectious Diseases
|
March 22, 2019
Variations in the Occurrence of Resistance Phenotypes and Carbapenemase Genes Among <i>Enterobacteriaceae</i> Isolates in 20 Years of the SENTRY Antimicrobial Surveillance Program
Mariana Castanheira, Lalitagauri M Deshpande, Rodrigo E Mendes, et al.
Antimicrobial Agents and Chemotherapy
|
March 25, 2024
<i>In vitro</i> development of resistance against antipseudomonal agents: comparison of novel β-lactam/β-lactamase inhibitor combinations and other β-lactam agents
Mariana Castanheira, John H Kimbrough, Jill Lindley, et al.
Journal of Clinical Microbiology
|
September 16, 2011
Determination of disk diffusion and MIC quality control ranges for GSK1322322, a novel peptide deformylase inhibitor
James E Ross, Nicole E Scangarella-Oman, Linda A Miller, et al.
Journal of Global Antimicrobial Resistance
|
December 7, 2020
Antimicrobial activity of dalbavancin against clinical isolates of coagulase-negative staphylococci from the USA and Europe stratified by species
Helio S Sader, Cecilia G Carvalhaes, Jennifer M Streit, et al.
Page
of 42